EvoPair™ is currently open for Pre-Seed discussions with visionary partners and institutional investors.
Choose your side
EvoPair™ is a non-medical, privacy-first platform for intentional parenthood, enabling individuals to assess reproductive compatibility using consumer genetic data, personal values, and declared reproductive intent — before conception and without romantic matching.
EvoPair builds the missing pre-clinical layer in reproductive decision-making.
We reduce genetic and social risks before people enter clinics, contracts or treatments.
This makes reproduction safer, cheaper and more intentional — without becoming a medical product.
This platform is designed as a non-medical, decision-support system. It does not diagnose, treat, prevent, or manage any medical conditions.
The system processes user-provided consumer genetic data solely to generate compatibility indicators for personal planning and matching purposes. No clinical recommendations, medical interpretations, or therapeutic guidance are provided. The platform does not operate as a laboratory, medical device, or healthcare service provider. As a result, it operates outside the scope of FDA medical device regulation.
EvoPair™ employs a "Processing-only" model for all genomic information to ensure maximum user security. Upon the upload of raw DNA data, the system extracts specific markers required for the Compatibility Score. Following this extraction:
Automatic Deletion: The original raw data file is permanently purged from our production servers immediately after processing.
Metadata Storage: Only the resulting compatibility indices (non-identifiable mathematical values) are retained to facilitate the matching process.
No Third-Party Sharing: EvoPair™ does not sell, lease, or share genetic raw data with third-party advertisers or pharmaceutical companies by design.
EvoPair™ | Patent Pending
Copyright © 2026 EvoPair. All rights reserved.
Reproductive Intent Infrastructure is a proprietary research framework. The methodology and pilot design are subject to pending patent applications.
AI-assisted Compatibility Research